Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
5
×
national blog main
biotech
clinical trials
europe blog main
fda
national top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
biogen
boston blog main
boulder/denver blog main
boulder/denver top stories
brexit
detroit blog main
detroit top stories
drugs
europe
falsified medicines
indiana blog main
indiana top stories
innovation
labeling
mhra
new york blog main
new york top stories
regulations
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
uk
wisconsin blog main
wisconsin top stories
abbvie
What
plans
5
×
end
medicines
brexit
charting
choppy
course
dynamic
period
post
regulation
regulatory
reveals
transition
uk
acquisitions
administration
angry
announced
anti
benefited
bio
cash
ceo
clearance
collabs
company
covid
crunch
daniel
deal
despite
didn’t
drug
fda
fear
gilead
gilead’s
goal
help
Language
unset
Current search:
xconomy.com
×
plans
×
national
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans